GlobeNewsWire
10 May 2026, 20:05 UTC · 23w ago
Verdict
Headline takes no side. We score RDNT +0.80 across five claims — strongly bullish.
+0.80strongly bullish
More positive than 90% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
RadNet raised its 2026 Imaging Center guidance for Revenue, Adjusted EBITDA, and Free Cash Flow due to strong operating trends that continued through early May.
So whatRaising full-year guidance on key financial metrics signals stronger-than-expected forward earnings and cash generation, directly driving valuation revisions.
More positive than 99% of claims this week
RadNet's Digital Health Annual Recurring Revenue nearly doubled to $96.9 million from $49.8 million in the prior year quarter, while new DeepHealth business signed in Q1 totaled over $16 million in Total Contract Value.
The explosive growth in high-margin recurring software revenue and a robust commercial pipeline validates the digital health business model and adds a premium growth vector to the stock.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 98% of claims this week
Total Company Revenue grew 22.1% and Adjusted EBITDA grew 36.3% year-over-year, despite severe winter weather causing an estimated $13 million revenue and $9 million EBITDA headwind.
So whatStrong organic growth and margin expansion achieved despite a significant one-time weather disruption demonstrates underlying operating resilience and better-than-expected cost controls.
More positive than 98% of claims this week
RadNet formed a new health system joint venture with Trinity Health’s Saint Alphonsus Health System, serving as a blueprint for future partnerships that integrate its operational, clinical, and DeepHealth AI solutions.
So whatThis validates the commercial scalability of RadNet's combined physical and digital offerings to major health systems, opening a new, high-margin recurring revenue channel beyond owned outpatient centers.
More positive than 90% of claims this week
RadNet expects that by year-end, over 70% of its studies could run through clinical AI, with all radiologist reports processed through DeepHealth's AI-powered auto-impression engine to measurably improve operating expenses.
So whatFull internal deployment of AI workflow tools at scale promises tangible future operating leverage and cost reductions, expanding consolidated margins.
More positive than 88% of claims this week
Which stocks this story touches
More positive than 90% of ticker scores this week
The company reported record first quarter performance, significant revenue and EBITDA growth, and raised its 2026 guidance.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
1h ago
+17.6%
Price agrees with the score
$68.41 vs $58.19 close before publication (May 8) · not market-adjusted
RDNT chart →
